Literature DB >> 32498595

Staphylococcal Vaccine Antigens related to biofilm formation.

Bahman Mirzaei1,2, Ryhaneh Babaei2, Sina Valinejad2.   

Abstract

The number and frequency of multidrug-resistant (MDR) strains as a frequent cause of nosocomial infections have increased, especially for Methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis, in part due to device-related infections. The transition to antibiotic-resistance in related bacterial genes and the capability for immune escape have increased the sustainability of biofilms produced by these bacteria. The formation and changes in biofilms have been suggested as a target to prevent or treat staphylococcal infections. Thus, this study reviews the development of candidate staphylococcal vaccines by database searching, and evaluates the immunogenicity and efficacy profiles of bacterial components involved in biofilms. The literature suggests that using common staphylococcal vaccine antigens and multivalent vaccines should further enhance vaccine efficacy.

Entities:  

Keywords:  staphylococcus aureus ; staphylococcus epidermidis ; Candidate vaccines; biofilm; device-related infection; immunotherapy; nosocomial pathogen; prophylaxis

Mesh:

Substances:

Year:  2020        PMID: 32498595      PMCID: PMC7872035          DOI: 10.1080/21645515.2020.1767449

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  77 in total

1.  A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor.

Authors:  Nina Hirschhausen; Tim Schlesier; M Alexander Schmidt; Friedrich Götz; Georg Peters; Christine Heilmann
Journal:  Cell Microbiol       Date:  2010-12       Impact factor: 3.715

2.  Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens.

Authors:  Andreas Meinke; Tamás Henics; Markus Hanner; Duc Bui Minh; Eszter Nagy
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

3.  Autoinducer-2 increases biofilm formation via an ica- and bhp-dependent manner in Staphylococcus epidermidis RP62A.

Authors:  Ting Xue; Jingtian Ni; Fei Shang; Xiaolin Chen; Ming Zhang
Journal:  Microbes Infect       Date:  2015-01-28       Impact factor: 2.700

4.  Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation.

Authors:  Mohammad Shahrooei; Vishal Hira; Laleh Khodaparast; Ladan Khodaparast; Benoit Stijlemans; Soňa Kucharíková; Peter Burghout; Peter W M Hermans; Johan Van Eldere
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

Review 5.  Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants.

Authors:  Manisha Patel; David A Kaufman
Journal:  Expert Opin Biol Ther       Date:  2015-03-03       Impact factor: 4.388

6.  Synthesis of conjugated PIA-rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis.

Authors:  Bahman Mirzaei; Seyed Fazlollah Mousavi; Reyhane Babaei; Sara Bahonar; Seyed Davar Siadat; Mehdi Shafiee Ardestani; Mohammad Shahrooei; John Van Eldere
Journal:  J Med Microbiol       Date:  2019-04-16       Impact factor: 2.472

7.  Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis.

Authors:  M Gabriela Bowden; Wei Chen; Jenny Singvall; Yi Xu; Sharon J Peacock; Viviana Valtulina; Pietro Speziale; Magnus Höök
Journal:  Microbiology       Date:  2005-05       Impact factor: 2.777

8.  The presence of icaADBC is detrimental to the colonization of human skin by Staphylococcus epidermidis.

Authors:  K L Rogers; M E Rupp; P D Fey
Journal:  Appl Environ Microbiol       Date:  2008-08-08       Impact factor: 4.792

9.  Expression of Staphylococcus epidermidis SdrG increases following exposure to an in vivo environment.

Authors:  Bret R Sellman; Yekaterina Timofeyeva; Jasdeep Nanra; Adrienne Scott; James P Fulginiti; Yury V Matsuka; Steve M Baker
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

10.  A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics.

Authors:  Vannakambadi K Ganesh; Jose J Rivera; Emanuel Smeds; Ya-Ping Ko; M Gabriela Bowden; Elisabeth R Wann; Shivasankarappa Gurusiddappa; J Ross Fitzgerald; Magnus Höök
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

View more
  4 in total

1.  Methicillin- and Vancomycin-Resistant Staphylococcus aureus From Humans and Ready-To-Eat Meat: Characterization of Antimicrobial Resistance and Biofilm Formation Ability.

Authors:  Taisir Saber; Mohamed Samir; Rasha M El-Mekkawy; Eman Ariny; Sara Ramadan El-Sayed; Gamal Enan; Sawasn H Abdelatif; Ahmed Askora; Abdallah M A Merwad; Yasmine H Tartor
Journal:  Front Microbiol       Date:  2022-02-08       Impact factor: 5.640

2.  Evaluation of the Negative Predictive Value of Methicillin-Resistant Staphylococcus aureus Nasal Swab Screening in the Medical Intensive Care Units and Its Effect on Antibiotic Duration.

Authors:  Chih-Hsun Tai; Wei-Ling Liu; Sung-Ching Pan; Shih-Chi Ku; Fang-Ju Lin; Chien-Chih Wu
Journal:  Infect Drug Resist       Date:  2022-03-24       Impact factor: 4.003

3.  A General Map of Transcriptional Expression of Virulence, Metabolism, and Biofilm Formation Adaptive Changes of Staphylococcus aureus When Exposed to Different Antimicrobials.

Authors:  Zun Ren; Jinlong Yu; Jiafei Du; Yubo Zhang; Musha Hamushan; Feng Jiang; Feiyang Zhang; Boyong Wang; Jin Tang; Hao Shen; Pei Han
Journal:  Front Microbiol       Date:  2022-06-17       Impact factor: 6.064

4.  Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL/6 mice.

Authors:  Christopher P Klimko; Jennifer L Shoe; Nathaniel O Rill; Melissa Hunter; Jennifer L Dankmeyer; Yuli Talyansky; Lindsey K Schmidt; Caitlyn E Orne; David P Fetterer; Sergei S Biryukov; Mary N Burtnick; Paul J Brett; David DeShazer; Christopher K Cote
Journal:  Front Microbiol       Date:  2022-08-17       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.